Transaminase

Results: 178



#Item
51KeePEMalive (GA no.: [removed]Programme Review Day 2012 Brussels, 28th/29th November Steffen Møller-Holst SINTEF Materials & Chemistry

KeePEMalive (GA no.: [removed]Programme Review Day 2012 Brussels, 28th/29th November Steffen Møller-Holst SINTEF Materials & Chemistry

Add to Reading List

Source URL: www.fch-ju.eu

Language: English - Date: 2014-09-28 16:54:30
52Microsoft Word - PrelimFinal Steering Comm March[removed]docx

Microsoft Word - PrelimFinal Steering Comm March[removed]docx

Add to Reading List

Source URL: dnr.alaska.gov

Language: English - Date: 2012-01-10 14:20:25
53ALLEN BEALS, M.D., J.D.  MARYELLEN ODELL Commissioner of Health

ALLEN BEALS, M.D., J.D. MARYELLEN ODELL Commissioner of Health

Add to Reading List

Source URL: www.putnamcountyny.com

Language: English - Date: 2014-07-28 10:41:55
54Microsoft Word - Draft Steering Comm 27 Oct 09 just TCC+AMM

Microsoft Word - Draft Steering Comm 27 Oct 09 just TCC+AMM

Add to Reading List

Source URL: dnr.alaska.gov

Language: English - Date: 2012-01-10 14:20:26
55Minutes Approved March 23, 2009    Technical Working Group ‐ Steering Committee  Pebble Project  January 16, 2009 

Minutes Approved March 23, 2009   Technical Working Group ‐ Steering Committee  Pebble Project  January 16, 2009 

Add to Reading List

Source URL: dnr.alaska.gov

Language: English - Date: 2012-01-10 14:20:25
56Liver function monitoring scheme with Valdoxan  Valdoxan 25 mg  Initiation of 25mg ALT …………U/L AST …………U/L ALT …………U/L  Week 3

Liver function monitoring scheme with Valdoxan  Valdoxan 25 mg  Initiation of 25mg ALT …………U/L AST …………U/L ALT …………U/L  Week 3

Add to Reading List

Source URL: www.servier.com

Language: English - Date: 2014-01-29 08:20:32
57• 	 Active liver disease, which may include unexplained persistent elevations in hepatic transaminase levels (4) • 	 Women who are pregnant or may become pregnant (4, 8.1) • 	 Nursing mothers (4, 8.3) -------------

• Active liver disease, which may include unexplained persistent elevations in hepatic transaminase levels (4) • Women who are pregnant or may become pregnant (4, 8.1) • Nursing mothers (4, 8.3) -------------

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2009-04-21 16:03:04
58• 	 Active liver disease, which may include unexplained persistent elevations in hepatic transaminase levels (4) • 	 Women who are pregnant or may become pregnant (4, 8.1) • 	 Nursing mothers (4, 8.3) -------------

• Active liver disease, which may include unexplained persistent elevations in hepatic transaminase levels (4) • Women who are pregnant or may become pregnant (4, 8.1) • Nursing mothers (4, 8.3) -------------

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2009-03-31 14:51:04
59Minutes Approved 15 January 2009    Technical Working Group ‐ Geochemistry  Pebble Project  November 18, 2008 

Minutes Approved 15 January 2009   Technical Working Group ‐ Geochemistry  Pebble Project  November 18, 2008 

Add to Reading List

Source URL: dnr.alaska.gov

Language: English - Date: 2012-01-10 14:20:24
60Minutes Approved February 20, 2009    Technical Working Group ‐ Steering Committee  Pebble Project  November 14, 2008 

Minutes Approved February 20, 2009   Technical Working Group ‐ Steering Committee  Pebble Project  November 14, 2008 

Add to Reading List

Source URL: dnr.alaska.gov

Language: English - Date: 2012-01-10 14:20:24